fbpx

QQQ
+ 0.00
370.35
+ 0%
BTC/USD
-1487.03
41673.87
-3.45%
DIA
-0.02
348.63
-0.01%
SPY
+ 0.05
442.59
+ 0.01%
TLT
+ 0.00
146.37
+ 0%
GLD
+ 0.02
163.62
+ 0.01%

Exploratory Clinical Study Looks Into CBD For Blood Pressure Reduction

July 29, 2020 3:35 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Exploratory Clinical Study Looks Into CBD For Blood Pressure Reduction

Lexaria Bioscience Corp. (OTC:LXRP) (CSE:LXX) will launch a clinical study to assess the potential of CBD in blood pressure reduction.

The study will be conducted among volunteers with pre-hypertension or mild hypertension, using CBD formulated using Lexaria’s patented technology, DehydraTECH.

“The primary outcome will be automated measures of blood pressure and heart rate," the press release states. "Secondary outcome measures will include circulating plasma concentrations of CBD and assessment of key inflammatory markers associated with cardiovascular disease."

Lexaria Bioscience CEO Chris Bunka referenced a human clinical study Lexaria Bioscience conducted in 2018 showing that CBD processed with the company’s DehydraTECH technology was capable of lowering human blood pressure — even when generic CBD did not.

“Our larger 2020 human clinical study will seek to reproduce those results and improve upon them,” he added. “Currently, there are a variety of approved drugs that control or reduce blood pressure, but some of those drugs have worrisome side effects such as gastrointestinal distress, nausea, vomiting, or chronic fatigue."

Bunka's goal is for CBD formulations to provide a safer alternative with the same effectiveness, but far less side effects.

Courtesy image

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.


Related Articles

Cannabis Stock Gainers And Losers From December 30, 2020

Cannabis Stock Gainers And Losers From December 30, 2020

GAINERS: Flower One Hldgs (OTCQX: FLOOF) shares closed up 21.35% at $0.16 read more
Cannabis Stock Gainers And Losers From September 24, 2020

Cannabis Stock Gainers And Losers From September 24, 2020

GAINERS: Benchmark Botanics (PINK: BHHKF) shares closed up 61.15% at $0.16 read more
Cannabis Stock Gainers And Losers From September 3, 2020

Cannabis Stock Gainers And Losers From September 3, 2020

GAINERS: 48North Cannabis (OTC: NCNNF) shares closed up 16.57% at $0.14 read more
Cannabis Stock Gainers And Losers From August 17, 2020

Cannabis Stock Gainers And Losers From August 17, 2020

Gainers: iAnthus Capital Hldgs (PINK: ITHUF) shares closed up 52.46% at $0.09 Nova Mentis Life Science (PINK: LIBFF) shares closed up 28.18% at $0.16 read more